Jacobio Pharmaceuticals Co., Ltd.

This early-stage study tested a new cancer drug called JAB-8263 in 41 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find the highest safe dose and check for side effects. Researchers also looked for early signs that t…

This early-stage study tested a new drug called JAB-BX102, both alone and combined with an existing immunotherapy (pembrolizumab), in 21 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find safe dose levels and see if t…

This first-in-human study tested a new oral drug called JAB-3312 in 40 adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find the safest dose and see how the body processes the drug. Researchers also looked for early signs t…

This early-stage study tested a new oral drug, JAB-21822, in adults with advanced solid tumors (like lung or colon cancer) that have a specific genetic change called KRAS G12C. The main goals were to find a safe dose and see if the drug, given alone or with another cancer drug (c…